Anxiety Reduction Interventions for Stroke Survivors
Trial Summary
What is the purpose of this trial?
The purpose of this pilot study is to explore the impact that a structured anxiety reduction intervention program has on patients being discharged to home following an acute stroke in an academic medical center. Eligible participants will be screened and recruited by the research team through daily rounds. After completing the informed consent process, the research team will pull demographic information from the electronic health record (EHR) and REDCAP that includes ethnicity and support system. Participants will complete the Anxiety Screen Questionnaire (GAD-7 ANXIETY SURVEY) and will be provided with information regarding stroke support groups available with additional NYU Langone Health and the American Heart Association internet-based information regarding anxiety reduction (NYU Langone Health Anxiety Reduction Bundle). The participants will be encouraged to attend a stroke support group for 3 months and utilize the NYU Langone Health Anxiety Reduction Bundle provided. At the completion of the intervention (3 months), participants will be provided with the GAD-7 ANXIETY SURVEY again and a survey that includes open-ended questions and a program evaluation by email. Analysis will occur after final data is collected.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue them, but please confirm with the research team.
What data supports the idea that Anxiety Reduction Interventions for Stroke Survivors is an effective treatment?
The available research shows that Anxiety Reduction Interventions for Stroke Survivors can be effective. For example, one study on relaxation training found it could reduce self-reported tension in stroke patients. Another study highlighted the benefits of group therapy for anxiety disorders, noting that it helps patients understand and manage their anxiety better. These findings suggest that such interventions can help stroke survivors manage anxiety effectively.12345
What safety data exists for anxiety reduction treatments in stroke survivors?
The provided research does not directly address safety data for the specific treatments named (Anxiety Reduction Bundle, NYU Langone Health Anxiety Reduction Bundle, Anxiety Support Program). However, it includes studies on interventions for anxiety after stroke, such as relaxation training and group therapy, which may offer insights into the general safety and effectiveness of anxiety treatments in stroke survivors. The Cochrane Review and other studies suggest that these interventions are generally considered safe, focusing on reducing anxiety and improving psychological outcomes post-stroke.13456
Is the Anxiety Reduction Bundle a promising treatment for reducing anxiety in stroke survivors?
Research Team
Bibi Sangster
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for individuals who have recently had an acute stroke and are stable enough to be discharged home. They must be able to understand and communicate in English, not have cognitive impairments, have internet access including email, and be willing to participate in an anxiety reduction program.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Anxiety Reduction Bundle
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor